Our Studies
To date, we have successfully completed over 500 FDA-approved studies in the areas of allergy, asthma and immunological diseases. At any given time, we are running numerous studies, advancing the frontiers of research and the possibilities of treatments every day.
CURRENT STUDIES
To apply to participate in one of our studies, please go here. If you would like to participate in a specific study, please note that when you fill out our survey.
ENGAGE – Eosinophilic Gastritis (EoG) Study
Study Treatment: Dupixent Injection
Subjects: Adults and children over 12 with EoG
For full information go to this link in clinicaltrials.gov
Contact mnelsen@seattleallergy.org if interested in participating
VITESSE – Patch Study in Peanut Allergic Children
Study Treatment: DBV712 – Peanut Patch
Subjects: Peanut allergic children aged 4-7
For full information go to this link in clinicaltrials.gov
Contact tderovanessian@seattleallergy.org if interested in participating
NATRON – Hypereosinophilic Syndrome (HES)
Study Treatment: Benralizumab – monoclonal antibody injection
Subjects: People over 12 with HES
For full information go to this link in clinicaltrials.gov
Contact lmiller@seattleallergy.org if interested in participating
More Studies Coming Soon!
Fill out our survey to be contacted for future clinical research trials at our site
Novartis – One-month Study for Peanut Allergic Adults
Study Treatment: Oral Remibrutinib
Subjects: Peanut allergic adults aged 18-55
For full information go to this link in clinicaltrials.gov
Contact jfernandez@seattleallergy.org if interested in participating
REMIX KIDS – Chronic Spontaneous Urticaria (CSU) Hives Study
Study Treatment: Oral Remibrutinib
Subjects: Children aged from 12-18 with CSU
For full information go to this link in clinicaltrials.gov
Contact akunze@seattleallergy.org if interested in participating
More Studies Coming Soon!
Fill out our survey to be contacted for future clinical research trials at our site
NIMBLE – Eosinophilic Asthma Comparison Study
Study Treatment: Depemokimab compared with mepolizumab or benralizumab
Subjects: Adults and children over 12 with eosinophilic asthma currently taking mepolizumab or benralizumab
For full information go to this link in clinicaltrials.gov
Contact jfernandez@seattleallergy.org if interested in participating